Small Animal Cancer Imaqina Core Small laboratory animal models such as mice, rats and hamsters are widely used throughout the cancer research community at Washington University. Indeed, with the recent revolution in molecular biology, transgenic laboratory animal models, in particular, mice have become an indispensable part of the cancer research armamentarium. Animal models of cancer, however, can present the researcher with significant challenges in deciding how best to evaluate or analyze for the characteristics or effects of interest. Most often, for example, one wishes to follow each of the individual subjects that make up a sample population over an extended time period during which various procedures are carried out. Thus, invasive and/or destructive procedures, especially those that require sacrifice of the subject, are prohibitive. Under these circumstances, nondestructive imaging modalities, such as magnetic resonance imaging, positron emission tomography, and optical imaging are especially valuable. The goals and specific aims of the Small Animal Cancer Imaging Core remain essentially as initially described, namely to bring to the Washington University and St. Louis region cancer research communities a resource that offers state-of-the-art small animal magnetic resonance imaging, positron emission tomography, and optical imaging. As described in this document, optical imaging is being added as a new modality to the Core. The attributes of optical imaging complement those of positron emission tomography and magnetic resonance imaging. In particular, optical imaging offers extremely high signal detection sensitivity with target-specific (molecular) labeling while avoiding the difficulties inherent with radionuciides. Optical Imaging faces challenges in probing deep lying structures, a strength of PET, and in achieving high spatial resolution, a strength of MRI. Thus, the three modalities are complementary, rather than redundant, and offer great opportunities for multi-modal assessment of small animal cancer models.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-07
Application #
7497935
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
7
Fiscal Year
2007
Total Cost
$309,335
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Groves, Andrew P; Gettinger, Katie; Druley, Todd E et al. (2018) Special Therapy and Psychosocial Needs Identified in a Multidisciplinary Cancer Predisposition Syndrome Clinic. J Pediatr Hematol Oncol :
Andley, Usha P; Tycksen, Eric; McGlasson-Naumann, Brittney N et al. (2018) Probing the changes in gene expression due to ?-crystallin mutations in mouse models of hereditary human cataract. PLoS One 13:e0190817
Sáenz, José B; Mills, Jason C (2018) Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 15:257-273
Miller, Christopher A; Tricarico, Christopher; Skidmore, Zachary L et al. (2018) A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel RARG-CPSF6 fusion. Blood Adv 2:1295-1299
Ostrander, Elizabeth L; Koh, Won Kyun; Mallaney, Cates et al. (2018) The GNASR201C mutation associated with clonal hematopoiesis supports transplantable hematopoietic stem cell activity. Exp Hematol 57:14-20
Jeong, Mira; Park, Hyun Jung; Celik, Hamza et al. (2018) Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo. Cell Rep 23:1-10
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Copper, Tara Conway; Jeffe, Donna B; Ahmad, Fahd A et al. (2018) Emergency Information Forms for Children With Medical Complexity: A Qualitative Study. Pediatr Emerg Care :
Stephens, Calvin J; Kashentseva, Elena; Everett, William et al. (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. Gene Ther 25:139-156
Sharma, Piyush K; Dmitriev, Igor P; Kashentseva, Elena A et al. (2018) Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Ther 25:27-38

Showing the most recent 10 out of 1244 publications